Paroxetine
Paroxetine is a pharmaceutical drug with 125 clinical trials. Currently 6 active trials ongoing. Historical success rate of 87.0%.
Success Metrics
Based on 94 completed trials
Phase Distribution
Phase Distribution
16
Early Stage
15
Mid Stage
65
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.7%
94 of 111 finished
15.3%
17 ended early
6
trials recruiting
125
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Paroxetine Safety and Efficacy in Rheumatoid Arthritis
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation
Clinical Trials (125)
Paroxetine Safety and Efficacy in Rheumatoid Arthritis
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation
Management of Acute Tinnitus With Migraine Medications
Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause
The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients
Effects of Paroxetine on Cardiovascular Function in Septic Patients
Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects
Concentration-QT Study of Paroxetine in Healthy Adults
Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea
Lithium Versus Paroxetine in Major Depression
Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging (fMRI) Study With Paroxetine Treatment
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Amitriptyline and Paroxetine Treatment of Major Depression
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus
Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 125